Piramal Pharma Limited announced that Ms. Nathalie Leitch has tendered her resignation from the position of Non-Executive, Non-Independent Director of the Company with immediate effect on account of other professional commitments.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
155.3 INR | +0.85% |
|
+0.87% | +11.82% |
May. 14 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
May. 13 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.82% | 2.45B | |
+52.15% | 803B | |
-5.97% | 351B | |
+18.84% | 324B | |
+11.19% | 303B | |
+16.96% | 243B | |
+2.25% | 228B | |
+11.15% | 217B | |
+7.43% | 164B | |
-2.90% | 155B |
- Stock Market
- Equities
- PPLPHARMA Stock
- News Piramal Pharma Limited
- Piramal Pharma Limited Announces Resignation of Nathalie Leitch as Non-Executive, Non-Independent Director